Skip to main content

and
  1. Article

    Open Access

    Guaiac faecal occult blood test performance at initial and repeat screens in the English Bowel Cancer Screening Programme

    In many countries, screening for colorectal cancer (CRC) relies on repeat testing using the guaiac faecal occult blood test (gFOBT). This study aimed to compare gFOBT performance measures between initial and r...

    B Kearns, S Whyte, J Chilcott, J Patnick in British Journal of Cancer (2014)

  2. Article

    Open Access

    Reply: cost-effectiveness of population-based screening for colorectal cancer

    L Sharp, C Walsh, S Whyte, L Tilson, A O'Ceilleachair, C Usher in British Journal of Cancer (2013)

  3. Article

    Open Access

    Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopy

    Several colorectal cancer-screening tests are available, but it is uncertain which provides the best balance of risks and benefits within a screening programme. We evaluated cost-effectiveness of a population-...

    L Sharp, L Tilson, S Whyte, A O'Ceilleachair, C Walsh, C Usher in British Journal of Cancer (2012)

  4. Article

    Open Access

    Cost-effectiveness of oxaliplatin and capecitabine in the adjuvant treatment of stage III colon cancer

    For many years, the standard treatment for stage III colon cancer has been surgical resection followed by 5-fluorouracil in combination with folinic acid (5-FU/LV). Ongoing clinical trial evidence suggests tha...

    S Eggington, P Tappenden, A Pandor, S Paisley, M Saunders in British Journal of Cancer (2006)